Full-Time
Confirmed live in the last 24 hours
Cloud-based software for healthcare analytics
$15.63 - $19.24Hourly
Entry, Junior
Company Historically Provides H1B Sponsorship
Tampa, FL, USA
You match the following Inovalon's candidate preferences
Employers are more likely to interview you if you match these preferences:
Inovalon provides cloud-based software solutions that focus on improving data-driven healthcare. The company offers a platform that integrates real-time data access and advanced analytics, which helps healthcare organizations enhance patient care and operational efficiency. Inovalon's platform supports over 100 solutions for various healthcare operations, including revenue cycle management and care quality management. Clients, which include healthcare providers, payers, and pharmaceutical companies, pay subscription fees for access to these tools, which are designed to be user-friendly and compatible with existing systems. Inovalon also offers consulting services to help clients maximize their data and analytics capabilities. The company's goal is to empower healthcare organizations to use data effectively to achieve better clinical outcomes and improve their overall performance.
Company Size
1,001-5,000
Company Stage
IPO
Total Funding
N/A
Headquarters
Bowie, Maryland
Founded
1997
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Life Insurance
401(k) Company Match
Paid Vacation
Hybrid Work Options
Inovalon launches ai-powered Converged Record Review to improve risk score accuracy for health plans.
Annual client-rated survey recognizes Inovalon as top vendor for RCM Intelligence & Analytics Solutions in 2024.
What You Should Know:– Inovalon, an innovator in cloud-based healthcare data solutions, announced a strategic partnership with the MEDITECH Alliance.– The strategic collaboration empowers thousands of healthcare providers using MEDITECH’s electronic health record (EHR) systems to leverage Inovalon’s end-to-end revenue cycle management (RCM) solutions.Optimizing Reimbursement and Reducing ErrorsThe partnership tackles a significant challenge in healthcare: inefficient claims processing leading to delayed reimbursements and lost revenue for providers. Inovalon’s solutions address this issue by:Improved Efficiency and Accuracy: Inovalon’s Claims Management Pro and Eligibility Workflow solutions streamline the revenue cycle process, minimizing errors and ensuring claims are submitted accurately. This translates to: Reduced denials Faster reimbursements Improved cash flow for healthcare providersInovalon’s Claims Management Pro and Eligibility Workflow solutions streamline the revenue cycle process, minimizing errors and ensuring claims are submitted accurately. This translates to: Leveraging Powerful Data and Analytics: Inovalon’s RCM solutions are built upon the Inovalon ONE® Platform. This platform utilizes the industry’s largest collection of de-identified healthcare data, combined with advanced analytics, to provide valuable insights that optimize RCM processes.Benefits for MEDITECH CustomersMEDITECH’s extensive network of healthcare provider customers will gain significant advantages through this partnership:Reduced Costs: Improved claims accuracy and faster reimbursements lead to reduced administrative costs associated with denied claims and follow-up efforts.Improved claims accuracy and faster reimbursements lead to reduced administrative costs associated with denied claims and follow-up efforts. Enhanced Patient Satisfaction: Faster claim processing translates to quicker payment for patients, improving the overall patient experience.Faster claim processing translates to quicker payment for patients, improving the overall patient experience
BOWIE, Md., June 28, 2024 (GLOBE NEWSWIRE) - Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced a new partnership with the MEDITECH Alliance, an ecosystem of partner organizations with successfully proven and interoperable solutions with MEDITECH, a leading global electronic health record (EHR) provider.
What You Should Know:– A new study by Inovalon, a leader in healthcare data analytics, sheds light on racial and socioeconomic disparities in emergency department (ED) visits for patients with hepatocellular carcinoma (HCC), the most common type of liver cancer.– The study, conducted in collaboration with Genentech, a member of the Roche Group, and Thomas Jefferson University Hospital, highlights the significant impact of social determinants of health (SDOH) on access to quality liver cancer care.Liver Cancer and Disparities in CareHCC is a growing health concern, with the fastest-rising rate of cancer-related deaths in the United States. However, minority and vulnerable populations often experience later diagnoses, limited access to specialized care, and poorer outcomes. Social determinants of health, such as income, education, and access to healthy food and housing, play a significant role in these disparities.The Study: Race, Income, and ED UtilizationThe study, titled “Race/Ethnicity and Socioeconomic Position in Emergency Department Utilization in Patients with Hepatocellular Carcinoma,” was published in Future Oncology and is one of the first to examine the combined effects of race/ethnicity and income on HCC patient outcomes. Researchers analyzed data from over 22,000 patients with newly diagnosed HCC between 2015 and 2018.Key Findings:Higher ED use for Black and Hispanic patients: Black patients had 27% more ED visits compared to white patients, and Hispanic patients had 17% more visits.Black patients had 27% more ED visits compared to white patients, and Hispanic patients had 17% more visits. Racial disparities persist across income levels: Even among high-income patients, Black and Hispanic patients had significantly higher ED use compared to white patients.Even among high-income patients, Black and Hispanic patients had significantly higher ED use compared to white patients. Asian patients with lower ED utilization: Asian patients showed the lowest ED utilization, with 36% fewer visits than white patients.Asian patients showed the lowest ED utilization, with 36% fewer visits than white patients